Outlook Therapeutics Inc.

03/11/2026 | Press release | Distributed by Public on 03/11/2026 15:16

Management Change/Compensation (Form 8-K)

It has been a real honor and pleasure to serve on the Board of Directors of Outlook Therapeutics for the last few years.

As you are aware, I have taken on new responsibilities as CEO here at Wills Eye Hospital. As a result, time constraints are forcing me to limit my outside commitments.

To this end, and with regret and respect, I will need to step down from the Outlook Therapeutics board effective March 10, 2026.

I am so appreciative of the opportunity over the last years to work with you and the tremendous team at Outlook to bring new therapies to patients with unmet needs.

I wish the company the very best of luck. You can count on my continued support.

With warmest regards,

Julia A. Haller, MD
Chief Executive Officer and Ophthalmologist-in-Chief
Outlook Therapeutics Inc. published this content on March 11, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 11, 2026 at 21:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]